YAP/TAZ‐TEAD as an Executor of Focal Adhesion Mechanotransduction Suppressed by the Hippo Pathway

Although the Hippo pathway is a well‐established negative regulator of the YAP/TAZ–TEAD1–4 transcriptional complex, the molecular mechanisms that actively sustain YAP/TAZ–TEAD activation remain poorly defined. Integrating recent literature with systematic Cancer Dependency Map (DepMap) codependency analysis, we propose a working model wherein the TAZ/YAP–TEAD complex functions as a nuclear executor of the focal adhesion mechanotransduction cascade. This mechanotransduction arm is predicted to initiate at the plasma membrane by integrins α v β 5 (ITGAV/ITGB5), N‐cadherin (CDH2), and lysophosphatidic acid receptor 1 (LPAR1), which likely engage PKN2 and MARK2/3 signaling kinases downstream of the focal adhesion complex. Conversely, a cell‐surface triad comprising NRP1, PLXNA1, and KIRREL1 and EPHA2 may act as an upstream activator of the inhibitory Hippo pathway. Collectively, we propose that TAZ/YAP–TEAD activity is governed by a dynamic, reciprocal antagonism between the Hippo pathway and focal adhesion‐mediated mechanotransduction, with the latter serving as a positive driver sustaining YAP/TAZ functional activity.

Authors

Institutions

Publication Details

Journal
Advanced Science
Published
2026-11-19
DOI
https://doi.org/10.1002/advs.78240
Primary Topic
Hippo pathway signaling and YAP/TAZ
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

YAP/TAZ‐TEAD as an Executor of Focal Adhesion Mechanotransduction Suppressed by the Hippo Pathway

Wanjin Hong
Advanced Science
Hippo pathway signaling and YAP/TAZ
article

YAP/TAZ‐TEAD as an Executor of Focal Adhesion Mechanotransduction Suppressed by the Hippo Pathway

Wanjin Hong
article en

Abstract

Although the Hippo pathway is a well‐established negative regulator of the YAP/TAZ–TEAD1–4 transcriptional complex, the molecular mechanisms that actively sustain YAP/TAZ–TEAD activation remain poorly defined. Integrating recent literature with systematic Cancer Dependency Map (DepMap) codependency analysis, we propose a working model wherein the TAZ/YAP–TEAD complex functions as a nuclear executor of the focal adhesion mechanotransduction cascade. This mechanotransduction arm is predicted to initiate at the plasma membrane by integrins α v β 5 (ITGAV/ITGB5), N‐cadherin (CDH2), and lysophosphatidic acid receptor 1 (LPAR1), which likely engage PKN2 and MARK2/3 signaling kinases downstream of the focal adhesion complex. Conversely, a cell‐surface triad comprising NRP1, PLXNA1, and KIRREL1 and EPHA2 may act as an upstream activator of the inhibitory Hippo pathway. Collectively, we propose that TAZ/YAP–TEAD activity is governed by a dynamic, reciprocal antagonism between the Hippo pathway and focal adhesion‐mediated mechanotransduction, with the latter serving as a positive driver sustaining YAP/TAZ functional activity.

Advanced Science
Agency for Science, Technology and Research (SG)
Hippo pathway signaling and YAP/TAZ
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon